Shilpa Medicare Ltd
Shilpa Medicare | 530549
SHILPAMED - Share Price Chart
Stock Performance
Ratios
About Company
- Shilpa Medicare Limited, formerly known as Shilpa Antibiotics Private Limited was incorporated as a Private Company on November 20, 1987
- The Company changed the status to Public and the name of the Company changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003
- The Company is engaged in manufacturing of API, Formulation and Development service
- The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka
- It then started commercial production in November, 1989
- The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology
- It supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets
- While SML's underlying expertise is in the field of oncology, it also derives revenue from sale of non-oncology APIs
- With key products being Ambroxol (Mucolytic Agent) in Europe and Tranexmic Acid and Ursodeoxycholic Acid in India
- SML deals in high-quality Active Pharmaceutical Ingredients (APIs), Bulk drug, Intermediates, Formulations and Development service, New Drug Delivery Systems, Peptides / Biotech products and Specialty Chemicals etc
Ethics: Shilpa Medicare Ltd is flagged for
Animal Cruelty
The company engages directly in some form of animal cruelty through its business.
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Shilpa Medicare Ltd?
The current share price of Shilpa Medicare Ltd (Shilpa Medicare) is ₹814.95. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Shilpa Medicare Ltd?
The Price-to-Earnings (P/E) ratio of Shilpa Medicare Ltd is 814.95. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Shilpa Medicare Ltd?
Shilpa Medicare Ltd has a 52-week high of ₹834.10 and a 52-week low of ₹259.50. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Shilpa Medicare Ltd?
Shilpa Medicare Ltd offers a dividend yield of 0.07%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Shilpa Medicare Ltd?
The Earnings Per Share (EPS) of Shilpa Medicare Ltd is ₹14.54. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Shilpa Medicare Ltd?
Shilpa Medicare Ltd has a Return on Equity (ROE) of 3.88%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
